BeiGene (BGNE) Catches Eye: Stock Jumps 8.3%
BeiGene, Ltd. BGNE was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $107 –$130.1 in the past one-month time frame, witnessed a sharp increase yesterday.
The company has seen four positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for BeiGene. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
BeiGene currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
BeiGene, Ltd. Price
BeiGene, Ltd. Price | BeiGene, Ltd. Quote
Investors interested in the Medical - Biomedical and Genetics industry may consider Gilead Sciences, Inc. GILD, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is BGNE going up? Or down? Predict to see what others think:Up or Down
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report
BeiGene, Ltd. (BGNE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research